Origena Consulting
@origena.bsky.social
From bench to clinic and beyond.
https://www.origenaconsulting.fr
#Infectiousdiseases #HIVpx #GlobalHealth #CapacityBuilding #Vaccines
https://www.origenaconsulting.fr
#Infectiousdiseases #HIVpx #GlobalHealth #CapacityBuilding #Vaccines
Laurent Fraisse (Drugs for Neglected Diseases initiative) offers an in-depth look at how major Pharma Co. in the Global North are scaling back infectious disease R&D, raising serious concerns for global health & equity, particularly in the Global South. origenaconsulting.substack.com/p/pharmas-re...
October 10, 2025 at 9:08 AM
Laurent Fraisse (Drugs for Neglected Diseases initiative) offers an in-depth look at how major Pharma Co. in the Global North are scaling back infectious disease R&D, raising serious concerns for global health & equity, particularly in the Global South. origenaconsulting.substack.com/p/pharmas-re...
September 3, 2025 at 11:43 AM
September 2, 2025 at 11:32 AM
Belong Public Consultation | Clinical Trial Eligibility Criteria for Participants with HIV: Guidance on Improving Inclusion in Non-HIV Trials
www.eatg.org/news/belong-...
www.eatg.org/news/belong-...
August 6, 2025 at 1:17 PM
Belong Public Consultation | Clinical Trial Eligibility Criteria for Participants with HIV: Guidance on Improving Inclusion in Non-HIV Trials
www.eatg.org/news/belong-...
www.eatg.org/news/belong-...
Clinical Trial Eligibility for Participants with HIV: Guidance on Improving Inclusion in Non-HIV Trials For Public Consultation www.eatg.org/news/belong-...
August 2, 2025 at 5:24 PM
Clinical Trial Eligibility for Participants with HIV: Guidance on Improving Inclusion in Non-HIV Trials For Public Consultation www.eatg.org/news/belong-...
L'#Europe pour la science, la #science pour la santé, la #santé pour tous ! Signer la lettre ouverte
#SOS4EUHealthInnovation
sos4euhealthinnovation.org
#SOS4EUHealthInnovation
sos4euhealthinnovation.org
May 15, 2025 at 11:41 AM
L'#Europe pour la science, la #science pour la santé, la #santé pour tous ! Signer la lettre ouverte
#SOS4EUHealthInnovation
sos4euhealthinnovation.org
#SOS4EUHealthInnovation
sos4euhealthinnovation.org
Europe for science. Science for health. Health for all.
www.SOS4EUHealthInnovation.org.
#SOS4EUHealthInnovation
www.SOS4EUHealthInnovation.org.
#SOS4EUHealthInnovation
May 15, 2025 at 9:13 AM
Europe for science. Science for health. Health for all.
www.SOS4EUHealthInnovation.org.
#SOS4EUHealthInnovation
www.SOS4EUHealthInnovation.org.
#SOS4EUHealthInnovation
Earlier this year, I offered free 45-minute one-off coaching and mentoring sessions to early- and mid-career researchers based in low- and middle-income countries. Here are my thoughts on how it went and what I learned.
www.linkedin.com/pulse/learni...
www.linkedin.com/pulse/learni...
April 15, 2025 at 10:35 AM
Earlier this year, I offered free 45-minute one-off coaching and mentoring sessions to early- and mid-career researchers based in low- and middle-income countries. Here are my thoughts on how it went and what I learned.
www.linkedin.com/pulse/learni...
www.linkedin.com/pulse/learni...
In vitro diagnostics (IVDs) are central for preventing, diagnosing & treating infectious diseases. Enhanced IVD access promises improved healthcare outcomes. But challenges such as regulatory disparities continue to impede widespread IVD availability esp. in LMICs journals.plos.org/globalpublic...
April 11, 2025 at 3:42 PM
In vitro diagnostics (IVDs) are central for preventing, diagnosing & treating infectious diseases. Enhanced IVD access promises improved healthcare outcomes. But challenges such as regulatory disparities continue to impede widespread IVD availability esp. in LMICs journals.plos.org/globalpublic...
#HIV Px needs a range of complementary prevention & treatment tools. More efforts are needed to highlight the progress & benefits of Europe HIV vaccine R&D. HIV/AIDS epidemic still persists in Europe. With global health in turmoil, an HIV vaccine remains essential journals.plos.org/globalpublic...
April 11, 2025 at 1:43 PM
#HIV Px needs a range of complementary prevention & treatment tools. More efforts are needed to highlight the progress & benefits of Europe HIV vaccine R&D. HIV/AIDS epidemic still persists in Europe. With global health in turmoil, an HIV vaccine remains essential journals.plos.org/globalpublic...
February 4, 2025 at 1:57 PM
February 4, 2025 at 12:57 PM
January 29, 2025 at 1:46 PM
Ensuring upfront management of IP for HIV vaccine. #medicinepatentpool
October 7, 2024 at 4:00 PM
Ensuring upfront management of IP for HIV vaccine. #medicinepatentpool
October 7, 2024 at 3:43 PM
Beyond prevention : harnessing #HIV#vaccine for cure #hivr4p
October 6, 2024 at 5:35 PM
Beyond prevention : harnessing #HIV#vaccine for cure #hivr4p
October 6, 2024 at 3:52 PM
October 6, 2024 at 3:33 PM
Belong – Inclusion of People living with HIV in non-HIV clinical trials
www.eatg.org/projects/bel...
www.eatg.org/projects/bel...
November 15, 2023 at 9:11 AM
Belong – Inclusion of People living with HIV in non-HIV clinical trials
www.eatg.org/projects/bel...
www.eatg.org/projects/bel...
Playing with data visualisation: Rate of #HIV acquisition in #Europe 2021
September 15, 2023 at 3:35 PM
Playing with data visualisation: Rate of #HIV acquisition in #Europe 2021
#WHO courses on #Mpox completed!
openwho.org/courses/mpox...
openwho.org/courses/mpox...
August 22, 2023 at 2:06 PM
#WHO courses on #Mpox completed!
openwho.org/courses/mpox...
openwho.org/courses/mpox...